Objetivos: Avaliar o efeito da inibição de triptase, com o uso da droga nafamostate mesilate (NM), sobre o desenvolvimento de doença periodontal induzida em ratos. Metodologia: Oitenta ratos Wistar machos foram divididos aleatoriamente em quatro grupos. Um grupo controle com injeção diária de NaCl 0,9%, grupo NM (injeção diária de 0.1mg/kg de NM, ip), grupo ligadura (colocada ao redor do primeiro molar inferior direito), e grupo NM + Ligadura. A quantidade de perda óssea alveolar (POA) na porção mesial da face lingual da raiz mésio-lingual do primeiro molar inferior foi determinada após o sacrifício aos sete e 14 dias com o auxílio de um estereomicroscópio, e a atividade de mieloperoxidase (MPO) foi analisada nos tecidos gengivais. Resultados: A inibição da triptase levou à diminuição significativa (p <0,05) de POA em animais submetidos à ligadura e periodontite induzida. A inibição da triptase pelo NM não apenas preveniu o início da POA aos sete dias de experimento (0,44mm 0,16 e 0,60mm 0,22, p<0,05, NM + Ligadura versus Controle), como também diminuiu significativamente a POA aos 14 dias (0,97mm 0,17 versus 1,82mm 0,26, p <0,001, NM + Ligadura versus Ligadura). Além disso, a inibição da triptase diminuiu significativamente a atividade de MPO aos 14 dias (p<0.05). Conclusão: Os dados do presente estudo sugerem que a inibição da triptase modificou a progressão da periodontite induzida experimentalmente em ratos. / Aim: To evaluate the effect of inhibition of tryptase, with the drug nafamostate mesylate (NM) on the development of periodontal disease induced in rats. Methodology: Eighty (80) male Wistar rats were randomly separated into four study groups as follows: saline Control group, NM group (daily injection of 0.1mg/kg body weight of NM, i.p.), Ligature group (ligature placed at the gingival margin level of lower right first molars), and NM + Ligature group. The amount of alveolar bone loss (ABL) around the mesial root surface of the first mandibulary molar was determined at sacrifice at seven and 14 days with the aid of a stereomicroscope, and the myeloperoxidase activity (MPO) was analyzed at the gingival tissues. Results: NM led to significantly (p<0.05) decreased ABL in animals subjected to ligature induced periodontitis. Tryptase inhibition not only prevented the onset of significant ABL at seven days of the experiment (0.440.16 and 0.600.22, p>0.05, NM+Ligature and Control, respectively) but also significantly decreased the ABL when compared with the Ligature group at 14 days (0.970.17 versus 1.820.26, p<0.001). In addition, NM significantly decreased MPO activity at 14 days (p<0.05). Conclusion: These data provide evidence that tryptase inhibition may modify the progression of experimentally induced periodontitis in rats.

Systemic mastocytosis is a rare disease involving the infiltration and accumulation of active mast cells within any organ system. By far, the most common organ affected is the skin. Cutaneous manifestations of mastocytosis, including Urticaria Pigmentosa (UP), cutaneous mastocytoma or telangiectasia macularis eruptive perstans (TMEP), may indicate a more serious and potentially life-threatening underlying disease. The presence of either UP or TMEP in a patient with anaphylactic symptoms should suggest the likelihood of systemic mastocytosis, with the caveat that systemic complications are more likely to occur in patients with UP. TMEP can usually be identified by the typical morphology, but a skin biopsy is confirmative. In patients with elevated tryptase levels or those with frequent systemic manifestations, a bone marrow biopsy is essential in order to demonstrate mast cell infiltration. Further genetic testing for mutations of c-kit gene or the FIP1L1 gene may help with disease classification and/or therapeutic approaches. Rarely, TMEP has been described with malignancy, radiation therapy, and myeloproliferative disorders. A few familial cases have also been described. In this review, we discuss the clinical features, diagnosis and management of patients with TMEP. We also discuss the possible molecular pathogenesis and the role of genetics in disease classification and treatment.

No description available.

<p>Mast cells are key effector cells in allergic and inflammatory diseases. However, their primary role is most likely in host defence against parasitic and bacterial infections. Mast cells are a particularly rich source of serine proteases. These proteases belong to the chymase or the tryptase family, which are encoded from the mast cell chymase and the multigene tryptase loci, respectively. To better understand the biological functions and the molecular evolution of these enzymes we have studied the organisation of these two loci in species ranging from fish to human. We show that the mast cell chymase locus has evolved from a single founder gene to a complex locus during the past 200 Myr of mammalian evolution. Forty-five fish candidate genes for hematopoietic serine proteases were also identified. However, in phylogenetic analyses none of them grouped with individual branches holding mammalian mast cell chymase locus genes, indicating an independent parallel evolution in fish. </p><p>Studies of the evolution of the multigene tryptase locus showed that this locus has been highly conserved between marsupials and eutherians. However, no genes belonging to the individual subfamilies identified in eutherians could be identified in fish, amphibians or in birds, which also here indicates parallel evolution.</p><p>To study the evolution of specific cleavage specificities associated with these proteases, the extended cleavage specificity of opossum α-chymase was determined and found to be nearly identical to human mast cell chymase and the major mouse mast cell chymase mMCP-4. This indicates a strong pressure to maintain this specificity during mammalian evolution.</p><p>Basophils are rare blood cells with functions similar to mast cells that when mature almost completely lack mRNA. To study the proteome and to primarily characterize the granule protein content of basophils, an <i>in vitro</i> purification protocol was developed to obtain transcriptionally active umbilical cord blood-derived basophil precursors.</p>

<p>Otitis media with effusion (OME) is the major form of chronic relapsing inflammatory disease of the middle ear, constitutes the most common diagnosis for children under 15 years old and is the major cause of auditory dysfunction in pre-school children. OME is a disease more commonly found in allergic children. These studies sought to investigate the inflammatory response in the middle ear of patients and test the hypothesis that an allergic-like response might occur in the ear. Atopy was diagnosed by standard in vitro tests. Immunochemical techniques used to study classic allergic rhinitis and asthma were extrapolated to the evaluation of OME children whose effusion persisted beyond 2 months. Not only eosinophil cationic protein (ECP), tryptase, CD3-positive and IL-5 producing cells, but also myeloperoxidase (MPO) was found in middle ear fluid and/or mucosa in the majority of patients with OME and atopy. </p><p>Initially, levels of ECP, MPO, and tryptase were measured in effusions from 97 random OME patients whose atopic status was determined by in vitro testing to 12 inhalants and 5 foods. The response of eosinophils, neutrophils and mast cells in the middle ear was distinctly different between atopic and non-atopic patients (p<0.001) with higher levels of the cell markers in the atopic group of patients. This suggested that 1) perhaps OME was predominantly a disease of atopics and that 2) they differed in their response from non-atopics.</p><p>Tryptase was measured in middle ear effusions from 38 patients with OME, 94.7% of whom were atopic by in vitro testing. Tryptase was elevated only in the effusion of atopic patients as compared to 5 controls (p<0.01). Biopsies stained histochemically for tryptase showed evidence of mast cells in the mucosa and submucosa from 6 of 8 OME ears but absent in 4 normals.</p><p>Middle ear biopsies, embedded in a plastic resin to improve the structural preservation, from 5 patients with OME and 5 normals were evaluated for the presence of eosinophils and neutrophils with monoclonal antibodies against 4 specific granule proteins. Eosinophils and neutrophils were present in the mucosa and mucus in significantly higher numbers than in the control group.</p><p>In an effort to determine whether the middle ear itself might be involved in allergic disease, evidence that some of the cells, mediators and cytokines associated specifically with a Th-2 response were sought for in the middle ear mucosa of these children. Middle ear biopsies from 7 atopic patients with OME and 4 controls demonstrated the presence of activated eosinophils, CD-3+ T cells and IL-5 mRNA cells only in the mucosa from atopic OME children. </p><p>Conclusion: Effusion and mucosal biopsies containing ECP, tryptase, and/or IL-5 mRNA cells, CD3+ T cells, eosinophils, and mast cells indicate that many of the mediators and cells essential to the production of a Th-2 immune mediated response are present in ears with chronic effusion. The increased levels of MPO in atopic patients further suggest that the general inflammatory response to putative inciting agents such as bacterial and viral products may be altered in atopy. These studies support the hypothesis that the exaggerated inflammation within the middle ear associated with most cases of OME is possibly the result of an atopic response within the middle ear itself.</p>

Otitis media with effusion (OME) is the major form of chronic relapsing inflammatory disease of the middle ear, constitutes the most common diagnosis for children under 15 years old and is the major cause of auditory dysfunction in pre-school children. OME is a disease more commonly found in allergic children. These studies sought to investigate the inflammatory response in the middle ear of patients and test the hypothesis that an allergic-like response might occur in the ear. Atopy was diagnosed by standard in vitro tests. Immunochemical techniques used to study classic allergic rhinitis and asthma were extrapolated to the evaluation of OME children whose effusion persisted beyond 2 months. Not only eosinophil cationic protein (ECP), tryptase, CD3-positive and IL-5 producing cells, but also myeloperoxidase (MPO) was found in middle ear fluid and/or mucosa in the majority of patients with OME and atopy. Initially, levels of ECP, MPO, and tryptase were measured in effusions from 97 random OME patients whose atopic status was determined by in vitro testing to 12 inhalants and 5 foods. The response of eosinophils, neutrophils and mast cells in the middle ear was distinctly different between atopic and non-atopic patients (p&lt;0.001) with higher levels of the cell markers in the atopic group of patients. This suggested that 1) perhaps OME was predominantly a disease of atopics and that 2) they differed in their response from non-atopics. Tryptase was measured in middle ear effusions from 38 patients with OME, 94.7% of whom were atopic by in vitro testing. Tryptase was elevated only in the effusion of atopic patients as compared to 5 controls (p&lt;0.01). Biopsies stained histochemically for tryptase showed evidence of mast cells in the mucosa and submucosa from 6 of 8 OME ears but absent in 4 normals. Middle ear biopsies, embedded in a plastic resin to improve the structural preservation, from 5 patients with OME and 5 normals were evaluated for the presence of eosinophils and neutrophils with monoclonal antibodies against 4 specific granule proteins. Eosinophils and neutrophils were present in the mucosa and mucus in significantly higher numbers than in the control group. In an effort to determine whether the middle ear itself might be involved in allergic disease, evidence that some of the cells, mediators and cytokines associated specifically with a Th-2 response were sought for in the middle ear mucosa of these children. Middle ear biopsies from 7 atopic patients with OME and 4 controls demonstrated the presence of activated eosinophils, CD-3+ T cells and IL-5 mRNA cells only in the mucosa from atopic OME children. Conclusion: Effusion and mucosal biopsies containing ECP, tryptase, and/or IL-5 mRNA cells, CD3+ T cells, eosinophils, and mast cells indicate that many of the mediators and cells essential to the production of a Th-2 immune mediated response are present in ears with chronic effusion. The increased levels of MPO in atopic patients further suggest that the general inflammatory response to putative inciting agents such as bacterial and viral products may be altered in atopy. These studies support the hypothesis that the exaggerated inflammation within the middle ear associated with most cases of OME is possibly the result of an atopic response within the middle ear itself.

Mast cells are key effector cells in allergic and inflammatory diseases. However, their primary role is most likely in host defence against parasitic and bacterial infections. Mast cells are a particularly rich source of serine proteases. These proteases belong to the chymase or the tryptase family, which are encoded from the mast cell chymase and the multigene tryptase loci, respectively. To better understand the biological functions and the molecular evolution of these enzymes we have studied the organisation of these two loci in species ranging from fish to human. We show that the mast cell chymase locus has evolved from a single founder gene to a complex locus during the past 200 Myr of mammalian evolution. Forty-five fish candidate genes for hematopoietic serine proteases were also identified. However, in phylogenetic analyses none of them grouped with individual branches holding mammalian mast cell chymase locus genes, indicating an independent parallel evolution in fish. Studies of the evolution of the multigene tryptase locus showed that this locus has been highly conserved between marsupials and eutherians. However, no genes belonging to the individual subfamilies identified in eutherians could be identified in fish, amphibians or in birds, which also here indicates parallel evolution. To study the evolution of specific cleavage specificities associated with these proteases, the extended cleavage specificity of opossum α-chymase was determined and found to be nearly identical to human mast cell chymase and the major mouse mast cell chymase mMCP-4. This indicates a strong pressure to maintain this specificity during mammalian evolution. Basophils are rare blood cells with functions similar to mast cells that when mature almost completely lack mRNA. To study the proteome and to primarily characterize the granule protein content of basophils, an in vitro purification protocol was developed to obtain transcriptionally active umbilical cord blood-derived basophil precursors.

Submitted by HELENA RIBEIRO SOUZA null (helena.riber@hotmail.com) on 2016-08-11T15:45:49Z No. of bitstreams: 1 Dissertação Helena R Souza.pdf: 28021261 bytes, checksum: cfa8bae6ea9a632c8ff6462cc740385a (MD5) / Approved for entry into archive by Ana Paula Grisoto (grisotoana@reitoria.unesp.br) on 2016-08-12T19:10:30Z (GMT) No. of bitstreams: 1 souza_hr_me_sjrp.pdf: 28021261 bytes, checksum: cfa8bae6ea9a632c8ff6462cc740385a (MD5) / Made available in DSpace on 2016-08-12T19:10:30Z (GMT). No. of bitstreams: 1 souza_hr_me_sjrp.pdf: 28021261 bytes, checksum: cfa8bae6ea9a632c8ff6462cc740385a (MD5) Previous issue date: 2016-07-29 / O processo de reparo de lesões térmicas pode ser dividido nas fases de inflamação, proliferação e remodelação. No seu processo de desgranulação, os mastócitos (MCs) liberam fatores quimiotáticos, citocinas e proteases, como triptase e quimase, para o meio extracelular, contribuindo na degradação da matriz lesada e síntese de uma nova. Além disso, estudos indicam que os MCs armazenam a proteína anti-inflamatória anexina A1 (AnxA1), envolvida na inflamação, apoptose, crescimento e diferenciação celular. Contudo, não se conhecem relatos da expressão e função da AnxA1 no reparo de queimaduras. Diante disso, os objetivos desse estudo foram quantificar e avaliar a ativação, acúmulo de histamina e heterogeneidade para triptase e quimase dos MCs, bem como, verificar a expressão da AnxA1, quantificar macrófagos, e dosar as citocinas TNF-α, IL-1β, IL-6, IL-10 e a quimiocina MCP-1 em modelo de queimadura de segundo grau em ratos Wistar. Para o desenvolvimento da lesão os animais foram anestesiados e submetidos à aplicação de um bloco metálico aquecido no dorso. Os animais foram divididos em grupos controles e tratados com pomada de sulfadiazina de prata a 1% (SDP 1%). As análises foram realizadas em 3, 7, 14 e 21 dias após injúria, e também em fragmentos de pele normal. Avaliações macroscópicas e histopatológicas da cicatrização confirmaram as características de queimadura de segundo grau e a melhor evolução da cicatrização nos animais tratados. A quantificação dos MCs mostrou grande quantidade de células intactas na pele normal e redução significante dessas células nas fases de inflamação (dia 3) e de proliferação (dia 7). Nas fases de proliferação de matriz (dia 14) e remodelação (dia 21) foi verificada maior quantidade de MCs nos animais controles e essas células foram observadas, principalmente, desgranuladas no dia 14 e intactas no dia 21. Ainda, no grupo tratado aos 7 dias e em ambos os grupos aos 14 dias, foi encontrada diferença entre MCs com grande quantidade de histamina e MCs totais. A análise da heterogeneidade dos MCs revelou maior número de MCs positvos para triptase (MCT) do que para quimase (MCQ) na pele normal e redução de MCTs e MCQs nas primeiras fases da cicatrização. Contudo, na fase de remodelação, muitos MCQs foram observados no grupo controle. A expressão da AnxA1 foi fraca na pele normal com aumento nas fases de inflamação e de proliferação. Aos 21 dias após lesão, a expressão da AnxA1 foi maior nos animais tratados com SDP 1%, no estroma e também em regiões epiteliais próximas à neogênese dos anexos cutâneos. As análises das citocinas mostraram aumento das pró-inflamatórias TNF-α, IL-1β e IL-6, e da citocina anti-inflamatória IL-10, nas fases iniciais do reparo, especialmente nos dias 3 e 7. O mesmo foi observado com relação a quimiocina MCP-1 e a quantificação de macrófagos. Nossos resultados evidenciaram diferenças no número de MCs e na imunomarcação da AnxA1 entre os grupos estudados, moduladas pelo tratamento com a SDP 1% e indicam que essas células e proteínas podem ser alvos terapêuticos no processo de regeneração de queimaduras. / The repair process of thermal injury can be divided into phases of inflammation, proliferation and remodeling. The mast cells (MCs) in their degranulation process, release chemotactic factors, cytokines and proteases, as tryptase and chymase, to the extracellular environment contributing to the degradation of damaged matrix and synthesis of a new one. Moreover, studies indicate that MCs store the antiinflammatory protein annexin A1 (AnxA1) which involved in inflammation, apoptosis, growth and cell differentiation. However, there are no known reports of the expression and function of AnxA1 in burns repair. Thus, the objectives of this study were to quantify, assess the activation, histamine accumulation and heterogeneity for tryptase and chymase of MCs, as well as, check the expression of AnxA1, associated with macrophages quantification and the levels of TNF-α, IL-1β, IL-6, IL-10 and MCP-1 in a second degree burn model in rats. For the development of the lesions, animals were anesthetized for applying a water-heated metal block in the dorso. The animals were divided into control and treated or not with the cream of silver sulfadiazine 1% (SDP 1%). The analyzes were performed on 3, 7, 14 and 21 days after injury, and also in normal skin fragments. Macroscopic and histopathological evaluations of healing confirmed the burning characteristics of second degree and the better progress of wound repair in treated animals. Quantification of MCs showed large amount of intact cells in normal skin and a significant reduction of these cells in the stages of inflammation (day 3) and proliferation (day 7). In the phases of matrix proliferation (day 14) and remodeling (day 21) it was observed increased amount of MCs, only in the control animals, and these cells were mainly degranulated on day 14, but intact on day 21. Also, in the treated group on day 7 and in both groups on day 14, it was found difference between MCs with large amounts of histamine and total MCs. The heterogeneity analysis revealed more MCs positves for tryptase (MCT) than for chymase (MCC) on normal skin and reduced MCTs and MCQs in the early stages of healing. However, in the remodeling phase, many MCCs were observed in the control group. The expression of AnxA1 was low in normal skin and increased in the stages of inflammation and proliferation. On 21 days after injury, the expression of AnxA1 was higher in animals treated with SDP 1% in the stroma and epithelial cells especially in regions close to neogenesis of skin attachments. Analysis of the inflammatory mediators showed an increase pro-inflammatory TNF-α, IL-1β and IL-6 and anti-inflammatory IL-10 cytokines in the early stages of the repair, especially on days 3 and 7. The same was observed for MCP-1 chemokine and quantification of macrophages. Our results showed differences in the number of MCs and AnxA1 expression between groups, that were modulated by treatment with the SDP 1%, indicating that these cells and protein can be used as therapeutic targets in burns regeneration process.

Submitted by JÚLIO HEBER SILVA (julioheber@yahoo.com.br) on 2016-12-19T17:52:15Z No. of bitstreams: 2 Tese - Maurício Barcelos Costa - 2014.pdf: 740997 bytes, checksum: fec1f12612ff6a41fbbbee9640600a35 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Rejected by Luciana Ferreira (lucgeral@gmail.com), reason: Júlio, falta o arquivo da tese. on 2016-12-26T12:31:54Z (GMT) / Submitted by JÚLIO HEBER SILVA (julioheber@yahoo.com.br) on 2017-01-02T15:41:57Z No. of bitstreams: 2 Tese - Maurício Barcelos Costa - 2014.pdf: 10731375 bytes, checksum: d59433128feb9bc7facacb81cb311a98 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2017-01-03T09:40:55Z (GMT) No. of bitstreams: 2 Tese - Maurício Barcelos Costa - 2014.pdf: 10731375 bytes, checksum: d59433128feb9bc7facacb81cb311a98 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2017-01-03T09:40:55Z (GMT). No. of bitstreams: 2 Tese - Maurício Barcelos Costa - 2014.pdf: 10731375 bytes, checksum: d59433128feb9bc7facacb81cb311a98 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2014-02-26 / Leprosy is a complex, chronic, infectious dermato-neurological disease that affects the skin and peripheral nerves especially during acute immune-inflammatory episodes known as type 1/T1R and type 2/T2R reactions. There is no experimental model for leprosy and leprosy skin lesions have been extensively used to unravel its multifaceted immunopathological mechanisms.This study investigated in situ expression of two distinct cell populations with important immunoregulatory roles: T regulatory (Treg) cells and mast cells (MC) in diverse skin diseases with emphasis on leprosy T1R and T2R. For the Treg cell study, 154 skin biopsies from 114 participants belonging to 3 groups were investigated: 1. Leprosy (n=74), 56 T1R (28-paired biopsies reactionfree/reactional from the same patient, 28 single reactional biopsy), 18 T2R (12 pairedreaction-free/reactional lesions, 6 single reactional biopsy); 2. Dermatoses: (n=29) noninfectious and cutaneous infectious diseases; 3. Normal controls: skin fragment of mammoplasty from healthy females that had cosmetic surgery. Double immunohistochemical detection of Treg cells was performed with automated platform for CD25 and Foxp3 staining. Quantifications of double immunostained Treg cells was performed (values expressed by mm2 ) blinded to the participants’ clinical status. For the mast cell study 80 skin biopsies from 3 groups were investigated: 40 newly diagnosed untreated leprosy patients (18 reaction-free, 11 T1R, 11 T2R), 29 patients with other dermatoses (the same as for Treg study) and 11 normal skins. Toluidine blue stained intact and degranulated MC counts/mm2 ; streptavidin-biotin-peroxidase immunostaining was used to detect tryptase/try+ and chymase/chy+ MCs and their density (median optical density) was evaluated. Results: Treg study: Not one CD25+ Foxp3+ Treg cell was seen in any of the 11 normal skin sections while variable numbers were detected in skin diseases (p<0.0001); the number of double stained cells was higher in infectious compared to non-infectious diseases (p=0.008). Treg cell numbers were comparable between leprosy and other infectious dermatoses (p=0.157) Treg cell counts in reactional lesions were higher than in reaction-free leprosy lesions (p<0.002). Paired biopsies of T1R or T2R reactional/reaction-free lesions showed xxvii increased numbers of Treg during T1R compared to reaction-free lesions from the same patient (p< 0.001). Treg cell median in T1R developed during MDT was slightly higher compared to T1R developed at diagnosis in naïve patients (p=0.047). There was a trend in increasing Treg cell numbers from the tuberculoid to borderline-lepromatous form, which showed the highest median value of Tregs, however this difference was not significant (p>0.8). Mast cell study: Infectious and non-infectious skin lesions showed higher numbers of degranulated than intact MC both for leprosy and other dermatoses, compared to normal skin. The numbers of degranulated MC were higher than intact MC regardless of the leprosy form (from tuberculoid/TT to lepromatous/LL), regardless of the occurrence of leprosy reactions (reactional and reaction-free) and regardless of the type of reaction (T1R/T2R). Try+ MC numbers and density were higher than chy+ MC in leprosy, in reaction-free and reactional lesions, particularly in T2R, but not in other dermatoses. Conclusions: Higher Treg numbers seen in T1R suggest Treg role in suppressing the exacerbated cell-mediated phenomenon that causes T1R. Differential expression/ of try+ and chy+ MC subsets was seen in leprosy compared to other skin diseases and to normal skin. However, neither leprosy form nor leprosy reaction was associated with MC changes in lesions suggesting that the Mycobacterium leprae infectious process per se dictates MC expression in leprosy skin lesions. / A hanseníase é uma complexa doença dermato-neurológica, crônica, de causa infecciosa que afeta a pele e os nervos periféricos, especialmente durante os episódios imunoinflamatórios agudos conhecidos com reações tipo 1/RT1 e tipo 2/RT2. Não existe modelo experimental para hanseníase e as lesões de pele têm sido extensivamente usadas para desvendar os multifacetados mecanismos imunopatológicos associados com a doença. Este estudo investigou a expressão in situ de duas distintas populações celulares que apresentam importante papel imunorregulatório: células Treg (Treg) e mastócitos (MC) em pele normal e diversas doenças cutâneas com ênfase nas reações hansênicas RT1 e RT2. Para o estudo de Tregs foram utilizadas 154 biópsias cutâneas de 114 participantes de três grupos: 1. Hanseníase (n=74), 56 RT1 (28-biópsias pareadas do mesmo paciente sem reação/durante reação, 28 biópsias únicas de RT1), 18 RT2 (12 biópsias pareadas sem reação/durante reação, 6 biópsias únicas de RT2); 2. Dermatoses: (n=29) doenças cutâneas não infecciosas e infecciosas. Controles Normais: fragmentos de peles obtidos de mamoplastias eletivas em mulheres saudáveis. Imunomarcação dupla CD25+ Foxp3+ de células Treg foi realizada em plataforma automatizada. Quantificação das células Treg duplo positivas foram feitas sem conhecimento da condição clínica do paciente (valores expressos em mm2 ). Para o estudo dos MC 80 biópsias de 3 grupos foram investigadas: 40 pacientes com hanseníase recém diagnosticados não tratados (18 sem reação, 11 RT1, 11 RT2), 29 pacientes com outras dermatoses e 11 biópsias de pele normal. Quantificação de MC intactos e desgranulados corados por azul de toluidina/mm2 ; imunomarcação streptavidina-biotina-peroxidase foi empregada para detectar MC triptase/try+ e chimase/chy+ e a densidade ótica (mediana da densidade ótica) foi avaliada. Resultados: Estudo das Tregs: Nenhuma célula Treg CD25+ Foxp3+ foi identificada em nenhuma das 11 amostras de pele normal, enquanto um número variável de Tregs foi identificado nas diversas doenças cutâneas (p<0.0001); o número de células Treg duplo positivas foi maior nas doenças infecciosas comparado com as não-infecciosas (p=0.008). Medianas de Treg entre hanseníase e outras doenças infecciosas foram semelhantes (p=0.157). Quantificação de Tregs em lesões reacionais foram maiores do que as sem reação (p<0.02). Nas biópsias pareadas de lesões de xxv RT1/sem reação ou RT2/sem reação, números maiores de Treg foram vistos durante a RT1 quando comparados com a não reacional do mesmo paciente (p< 0.001). Mediana de Treg em RT1 desenvolvidas durante MDT foi ligeiramente superior comparada a RT1 desenvolvida em pacientes sem de tratamento (p=0.047). Observou-se uma tendência de aumento no número das Tregs do polo tuberculoide em direção ao lepromatoso, mais especificamente até a forma borderline-lepromatosa que apresentou a maior mediana da quantificação de Treg, entretanto esta diferença não foi estatisticamente significativa (p>0.8). Estudo dos Mastócitos: lesões cutâneas de origem infecciosa e não infecciosa mostraram números aumentados de mastócitos desgranulados do que intactos tanto na hanseníase como nas outras dermatoses quando comparados com pele normal. Os números de mastócitos (MC) desgranulados foram maiores do que intactos, independente da forma de hanseníase (do polo tuberculoide/TT ao lepromatoso/LL), independente da ocorrência de reações hansênicas (lesão reacional/sem reação) e independente do tipo de reação (RT1/RT2). Número e densidade de mastócito triptase positivo (MC try+ ) estão aumentados em relação aos quimase positivo (MC chy+ ) na hanseníase, em pacientes com e sem reação, particularmente na RT2, mas não nas outras dermatoses. Conclusões: aumento nas Treg detectados durante RT1 sugerem papel supressor dessas células em eventos associados à resposta imune celular exacerbada, responsáveis pela RT1. Expressão diferencial das subpopulações de MC try+ e chy+ foi observada na hanseníase em relação a outras doenças cutâneas e pele normal. Entretanto, nem a forma da hanseníase, nem a ocorrência de reação hansênica, estava associada a mudanças nas subpopulações de MC nas lesões sugerindo que o processo infeccioso pelo Mycobacterium leprae per se direciona a expressão de MC nas lesões cutâneas da hanseníase.

Made available in DSpace on 2014-12-17T15:32:16Z (GMT). No. of bitstreams: 1 PedroPAS.pdf: 6126862 bytes, checksum: 3ae3ec2483d9e09d3a05fcd73782e862 (MD5) Previous issue date: 2008-02-27 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico / The giant cell fibroma is a benign neoplasm characterized by the presence of mono, bi or multinucleate cells, which can have a connection to the presence of mast cells. This research aims to analyze, descriptively and comparatively, the immunohystochemistry expression of the tryptase in mast cells of the giant cell f ibroma, f ibrous hyperplasia and samples of the normal oral mucosa. Thirty cases of giant cell fibroma, ten cases of fibrous hyperplasia and ten cases of normal oral mucosa were selected for the analysis of the immunohistochemistry expression, determination of the number of present mast cells, as well as their location and shape. It could be stated that there was a statistically signif icant difference (p<0,001) in relation to the quantity of mast cells among other samples analyzed where the giant cell f ibroma presented lesser quantity of mast cell and the hyperplasia showed higher concentration of this cellular type. Although the oral mucosa has presented a higher quantity of mast cells when compared to the giant cells fibroma, these were found in usual locations in the connective tissue in normal tissues. There could be noticed a statistically significant difference in relation to the number of non-granulated mast cells (p<0,001). On the areas of fibrosis, we could observe a statistically signif icant difference (p<0,006) among the samples. In relation to the present mast cells in perivascular location, no statistically signif icant difference was found. On the morphological analysis there was a predominance of oval mast cells. It was concluded that despite of the fact there was a lesser quantity of mast cells present in cases of giant cell f ibroma, they appeared to have a stronger relation to the present giant fibroblasts in this lesions, around 59,62%, being also evidenced a strong relation between these cells and the fibrosis areas in both cases of giant cell f ibroma and f ibrous hyperplasias and samples of normal oral mucosa, used as control group in our study, confirming, this way, the role of the mast cells as fibrinogenous inductor / O fibroma de c?lulas gigantes constitui-se de uma neoplasia benigna, caracterizada pela presen?a de c?lulas gigantes, mono, bi ou multinucleadas, c?lulas estas que podem guardar rela??o com a presen?a de mast?citos. O prop?sito desta pesquisa consistiu em analisar descritiva e comparativamente a express?o imuno-histoqu?mica da triptase em mast?citos de fibroma de c?lulas gigantes, hiperplasia fibrosa e esp?cimes de mucosa oral normal. Foram selecionados 30 casos de fibroma de c?lulas gigantes, 10 casos de hiperplasia fibrosa e 10 casos de mucosa oral normal, para a an?lise da express?o imuno-histoqu?mica, determina??o do n?mero de mast?citos presentes, bem como a sua forma e localiza??o. Constatou-se diferen?a estatisticamente significativa (p<0,001) em rela??o a quantidade de mast?citos entre os esp?cimes analisados, onde o fibroma de c?lulas gigantes apresentou a menor quantidade de mast?citos e a hiperplasia exibiu a maior concentra??o deste tipo celular. Embora a mucosa oral tenha apresentado uma maior quantidade de mast?citos quando comparado com os casos de f ibroma de c?lulas gigantes, estes se encontravam em localiza??es usuais no tecido conjuntivo em tecidos normais. Verif icou-se, diferen?a estatisticamente significativa, no que diz respeito ao n?mero de mast?citos n?o degranulados (p<0,001). Nas ?reas de fibrose, observamos diferen?a estatisticamente signif icativa (p<0,006) entre os esp?cimes. Com rela??o aos mast?citos presentes em localiza??o perivascular n?o se observou diferen?a estatisticamente significativa. Na an?lise morfol?gica verif icou-se uma predomin?ncia de mast?citos ovais. Concluiu-se que embora uma menor quantidade de mast?citos estivesse presente nos casos de fibroma de c?lulas gigantes, estes exibiam maior rela??o com os fibroblastos gigantes presentes nestas les?es em torno de 59,62%, sendo evidenciada tamb?m uma forte rela??o entre estas c?lulas e ?reas de fibrose tanto nos casos de fibroma de c?lulas gigantes como de hiperplasias fibrosas e esp?cimes de mucosa oral normal, utilizados como controle em nosso estudo, confirmando desta forma, o papel dos mast?citos como indutor fibrinog?nico